Reversing the siege.. Use of cholinesterase inhibitors such as neostigmine at the end of the process to reverse muscular paralysis produced by non-polarizing catheterization drugs

Cholinesterase inhibitors such as neostigmine are used at the end of the process to reverse muscular paralysis produced by non-polarizing catheter drugs, such as alkuronium and fecuronium.

Neustigmine should not be used with antispasmodic blockers, such as suxamethonium, because neostigmine will prolong muscle paralysis.

Neustigmine is also used to treat non-obstructive urinary retention that follows operations.

And for the use of cholinesterase inhibitors in muscle weakness.